Fed Circuit rules against Actavis knee pain generic

11-10-2019

Saman Javed

Fed Circuit rules against Actavis knee pain generic

Piyawat Nandeenopparit / Shutterstock.com

Actavis Laboratories cannot market a generic version of Horizon Pharma’s knee pain treatment, an appeals court has ruled.


Horizon Pharma, Actavis Laboratories, Pennsaid 2%, osteoarthritis, US Court of Appeals for the Federal Circuit, US Court for the District of New Jersey

More on this story

Horizon sues Actavis over inflammation cream
15-05-2017

LSIPR